ZOTA HEALTH CARE share price has plunged 4% and is presently trading at Rs 1,576.5.
Meanwhile, the BSE HEALTHCARE index is at 43,432.5 (down 0.2%).
Among the top losers in the BSE HEALTHCARE index today are Sun Pharma (down 2.9%) and ASTER DM HEALTHCARE (down 2.7%).
Biocon (up 1.9%) and MAX HEALTHCARE INSTITUTE (up 1.6%) are among the top gainers today.
Over the last one year, ZOTA HEALTH CARE has moved up from Rs 767.5 to Rs 1,576.5, registering a gain of Rs 809.1 (up 105.4%).
On the other hand, the BSE HEALTHCARE index has moved down from 44,145.5 to 43,432.5, registering a loss of 1.6% during the last 12 months.
The top losers among the BSE HEALTHCARE index stocks during this same period were COHANCE LIFESCIENCES (down 58.6%), SUN PHARMA ADV. RES. (down 42.7%) and POLY MEDICURE (down 35.8%).
Peak India: Grab this Opportunity Before it Catches More Momentum
The BSE Sensex is at 84,684.8 (up 0.1%).
The top gainers among the BSE Sensex today are TCS (up 1.5%) and Infosys (up 1.4%). The most traded stocks in the BSE Sensex are Tata Motors and ITC.
In the meantime, NSE Nifty is at 25,868.7 (up 0.2%). TCS and Infosys are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 81,748.6 to 84,684.8, registering a gain of 2,936.2 points (up 3.6%).
ZOTA HEALTH CARE net profit fell 33.0% YoY to Rs -162 million for the quarter ended September 2025, compared to a loss of Rs 122 million a year ago. Net sales rose 91.7% to Rs 1,289 million during the period as against Rs 673 million in July-September 2024.
For the year ended March 2025, ZOTA HEALTH CARE reported 295.5% decrease in net profit to Rs -567 million compared to net loss of Rs 143 million during FY24. Revenue of the company grew 62.1% to Rs 2,924 million during FY25.
The current Price to earnings ratio of ZOTA HEALTH CARE, based on rolling 12 month earnings, stands at -78.8.
Image source: DNY59/www.istockphoto.com
Equitymaster requests your view! Post a comment on "ZOTA HEALTH CARE Plunges 4%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!